Suchergebnisse - "Khorramimoghaddam, Alireza"

PubPharm (6)

1

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

2

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

3

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

4

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

5

Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide

enthalten in: Clinical breast cancer | 2023

von Biabani Ardakani, J. | Abedi, S. | Mardanshahi, A. | +7

6

Preclinical pharmacokinetic, biodistribution, radiation dosimetry, and toxicity studies of 99mTc-HYNIC-(Ser)3-LTVPWY : A novel HER2-targeted peptide radiotracer

enthalten in: Regulatory toxicology and pharmacology : RTP | 2020

von Biabani Ardakani, J. | Talebpour Amiri, F. | Khorramimoghaddam, A. | +3

1
[1]